| Entry |
|
|---|
| Name |
Sacrosidase (USAN);
Sucraid (TN) |
|---|
| Product |
|
|---|
| Sequence |
SMTNETSDRP LVHFTPNKGW MNDPNGLWYD EKDAKWHLYF QYNPNDTVWG TPLFWGHATS
DDLTNWEDQP IAIAPKRNDS GAFSGSMVVD YNNTSGFFND TIDPRQRCVA IWTYNTPESE
EQYISYSLDG GYTFTEYQKN PVLAANSTQF RDPKVFWYEP SQKWIMTAAK SQDYKIEIYS
SDDLKSWKLE SAFANEGFLG YQYECPGLIE VPTEQDPSKS YWVMFISINP GAPAGGSFNQ
YFVGSFNGTH FEAFDNQSRV VDFGKDYYAL QTFFNTDPTY GSALGIAWAS NWEYSAFVPT
NPWRSSMSLV RKFSLNTEYQ ANPETELINL KAEPILNISN AGPWSRFATN TTLTKANSYN
VDLSNSTGTL EFELVYAVNT TQTISKSVFA DLSLWFKGLE DPEEYLRMGF EVSASSFFLD
RGNSKVKFVK ENPYFTNRMS VNNQPFKSEN DLSYYKVYGL LDQNILELYF NDGDVVSTNT
YFMTTGNALG SVNMTTGVDN LFYIDKFQVR EVK |
|---|
| Type |
Peptide |
|---|
| Remark |
|
|---|
| Efficacy |
Enzyme replacement (sucrase-isomaltase) |
|---|
| Disease |
Congenital sucrase-isomaltase deficiency [DS: H00115] |
|---|
| Type |
Enzyme replacement therapy product |
|---|
| Target |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A16 OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
A16A OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
A16AB Enzymes
A16AB06 Sacrosidase
D05782 Sacrosidase (USAN) <US>
USP drug classification [BR:br08302]
Genetic, Enzyme, or Protein Disorder: Replacement, Modifiers, Treatment
Sacrosidase
D05782 Sacrosidase (USAN)
Target-based classification of drugs [BR:br08310]
Enzymes
Hydrolases (EC3)
Glycosidases
SI* [HSA_VAR:6476v1]
D05782 Sacrosidase (USAN) <US>
Pharmacogenomic biomarkers [br08341.html]
Germline mutations in genetic disorder treatments
D05782
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
